Is Photodynamic Therapy a Cost-Effective Treatment Option?
JUL 13, 2017 | CONTAGION® EDITORIAL STAFF
Caetano P. Sabino, BSc, PhD Student, Clinical Analysis, School of Pharmaceutical Sciences, University of Sao Paulo, explains if photodynamic therapy a cost-effective treatment option.
Interview Transcript (slightly modified for readability):
“[Photodynamic therapy] is very cost-effective. The dyes that we use as photosensitizers, for example [the one that we used], was methylene blue. It is a regular dye that is used on a day-to-day basis in microbiology labs for staining purposes [to help in] seeing bacteria under light microscopes. It is really cheap since we use it in much lower concentrations. And, light sources, nowadays, are very cheap and they are getting cheaper and cheaper. The LEDs are dropping their costs, due to their energy-efficiency and their illumination [capabilities]. In the same manner, we can use these technologies for photodynamic therapy treatments.”
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Influenza A (H3N2) has caused most of the illnesses in this severe flu season, but influenza B is becoming increasingly responsible for more infections as the flu season continues to hit the United States.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512